RxDoctor Payments DataLook up a doctor →

Harry Colfer

Interventional Cardiology · Petoskey, MINPI 1245273069

Payments from drug & device makers

$940,338in general payments, 2019–2025

Across 470 payments — averaging $2000.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$773K
  • Esperion Therapeutics, Inc.$89K
  • AstraZeneca$33K
  • Merck$27K
  • Siemens Medical Solutions USA, Inc.$7K
  • Abbott$4K
  • plus $7K from 18 others

What the payments were for

  • Consulting fees$6,07034%
  • Speaking & faculty fees$5003%
  • Travel & lodging$4,22024%
  • Food & beverage$7,13440%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$940,338 in reported general payments places this provider in the 95th percentile of 187 interventional cardiology providers in Michigan.

See all interventional cardiology providers in Michigan

Other interventional cardiology in Petoskey

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →